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ABSTRACT New Delhi metallo--lactamase 1 (NDM-1) is a subclass B1 metallo--
lactamase that exhibits a broad spectrum of activity against -lactam antibiotics. Here
we report the kinetic study of 6 Q119X variants obtained by site-directed mutagenesis
of NDM-1. All Q119X variants were able to hydrolyze carbapenems, penicillins and ﬁrst-,
second-, third-, and fourth-generation cephalosporins very efﬁciently. In particular,
Q119E, Q119Y, Q119V, and Q119K mutants showed improvements in kcat/Km values for
penicillins, compared with NDM-1. The catalytic efﬁciencies of the Q119K variant for
benzylpenicillin and carbenicillin were about 65- and 70-fold higher, respectively, than
those of NDM-1. The Q119K and Q119Y enzymes had kcat/Km values for ceftazidime
about 25- and 89-fold higher, respectively, than that of NDM-1.
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New Delhi metallo--lactamase 1 (NDM-1) plays a key role in antibiotic-resistantbacterial infections. NDM-1-producing bacteria have been identiﬁed from both
nosocomial and community-acquired infections, including urinary and pulmonary tract
infections, peritonitis, septicemia, and osteomyelitis, throughout the world (1–4). The
rapid emergence of this enzyme in multiple enteric bacteria is due to the favorable
genetic characteristics of the producing plasmids. Multiple antibiotic resistance genes
were found to be harbored by plasmids carrying the blaNDM-1 determinant (5, 6).
Therefore, NDM-1-producing strains showed high levels of resistance to a wide range
of -lactams, except monobactams, and also other antibiotic families (7). Structurally,
the NDM-1 enzyme displays the typical / sandwich architecture (8–11). The active
site of NDM-1 is surrounded by several loops that are responsible for substrate binding
and speciﬁcity and by two zinc ion binding sites, referred to as sites 1 and 2 (9). The two
zinc ions promote substrate catalysis; Zn-1 is tetracoordinated by the imidazole groups
of three histidine residues, H116, H118, and H196, and one water molecule, whereas
Zn-2 is pentacoordinated by H263, D120, and C221 (BBL numbering [12]) and two water
molecules. NDM-1 displays 32% sequence identity to the most common metallo--
lactamases (MBLs), IMP-1 and VIM-2 (9). Several studies demonstrated that, in MBLs,
D120 plays an important role in orienting the active site hydroxide ion, which serves as
a general base (13). A recent study of mutagenesis at position 120 in NDM-1 validated
the hypothesis that this residue acts as a strong Zn-2 ligand and is involved in the
interaction with substrate (13).
In the present study, to better understand the function of residue 119 in the NDM-1
enzyme, site saturation mutagenesis was performed on the blaNDM-1 gene (codons 247
to 249 [CAG]) to generate NDM-1 variants, named Q119X. The codon was randomized
using overlap-extension PCR, as described previously (14), with the pFM-NDM-1 plas-
mid as the template (15). Mutations were introduced into a PCR amplicon using the
mutagenic primers Q119X_for (5=-CTCACGCGCATNNNGACAAGATG) and Q119X_rev
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(5=-CATCTTGTCNNNATGCGCGTGAG), where N represents any of the four base pairs at
the codon position to be randomized. The external primers NDM_for (5=-GGGGGGGT
ACCCATATGGGTGAAATCCGCCCGA) and NDM_rev (5=-GGGGGGAGCTCGAGTCAGCGC
AGCTTGTCGGC) (KpnI/NdeI and SacI/XhoI restriction sites are shown in bold) were used
to amplify the entire blaNDM-1 gene. The ampliﬁcation product, digested with KpnI and
SacI, was ligated into the pBC-SK() Bluescript vector, and the ligation product was
transformed into Escherichia coli XL-1 Bluescript cells. Functional random mutants were
selected by growth in the presence of chloramphenicol (30 g/ml), ampicillin (100
g/ml), and meropenem (1 g/ml) and then were sequenced (ABI Prism 3500 eight-
capillary automated sequencer; Life Technologies, Monza, Italy) to identify the amino
acid substitutions at the randomized position. Among functional clones, 11 NDM-1
mutants were identiﬁed, i.e., Q119I, Q119S, Q119L, Q119Y, Q119C, Q119T, Q119F,
Q119K, Q119V, Q119E, and Q119M. The phenotypic proﬁles were characterized by the
microdilution method using a bacterial inoculum of 5  105 CFU/ml of E. coli XL-1/
pBC-SK-Q119X, according to Clinical and Laboratory Standards Institute (CLSI) perfor-
mance standards (16). The antimicrobial susceptibility to penicillins, cephalosporins,
and carbapenems was tested for all recombinant strains, including wild-type E. coli
XL-1/pBC-SK-NDM-1 and E. coli XL-1/pBC-SK (Table 1). Like NDM-1, all recombinant
mutants exhibited resistance to penicillins, cefazolin, cefotaxime, ceftazidime, and
cefepime. Only E. coli XL-1/pBC-SK-Q119E showed a MIC value of 8 g/ml for cefepime.
For cefoxitin, all recombinant strains showed MIC values higher than that of E. coli
XL-1/pBC-SK-NDM-1. For all strains tested, the imipenem and meropenem MIC values
ranged from 1 g/ml to 16 g/ml (Table 1). The mutants were categorized on the basis
of MIC values and, in this study, only the following 6 NDM-1 variants were investigated
on the basis of their phenotypic proﬁles: Q119C, Q119F, Q119E, Q119Y, Q119V, and
Q119K. For overexpression of the 6 NDM-1 variants, the blaQ119X mutant genes, without
signal peptide, were subcloned into the pET-24a() vector and transformed into E. coli
BL21(DE3). Puriﬁcation of the different NDM-1 mutants was performed as described
previously (15). From 400 ml of an overnight culture in tryptic soya broth (TSB), we
obtained about 5 mg of each NDM-1 mutant. Kinetic experiments were performed by
following the hydrolysis of each substrate at 25°C in 25 mM sodium phosphate buffer
(pH 7). The data were collected with a Perkin-Elmer Lambda 25 spectrophotometer
(Perkin-Elmer Italia, Monza, Italy). Steady-state kinetic analyses were performed under
initial-rate conditions using the Hanes plot linearization method (16). For Km values of
10 M, the Km values were determined as Ki values, using nitroceﬁn as the reporter
substrate (17). Each kinetic value is the mean of ﬁve different measurements; errors
were 5%. In Table 2, we show the Km, kcat, and kcat/Km values for Q119C, Q119F,
Q119E, Q119Y, Q119V, and Q119K variants, compared to NDM-1 (data for NDM-1 were
taken from reference 15), with some carbapenems, penicillins, and cephalosporins.
Imipenem and meropenem were good substrates for all Q119X variants analyzed,
with kcat values higher than that calculated for NDM-1 (except for Q119E with imi-
penem). The Q119F variant showed a kcat value for meropenem of 1,500 s1, about
TABLE 1 Pattern of -lactam resistance mediated by NDM-1 and Q119X mutants in E. coli XL-1, in comparison with E. coli XL-1/pBC-SK
Antibiotic
MIC (g/ml)
NDM-1 Q119C/Q119S Q119E Q119K Q119F/Q119T Q119Y/Q119I/Q119L Q119V pBC-SK
Benzylpenicillin 512 64 64 512 512 512 512 0.250
Piperacillin 256 512 512 512 512 512 512 0.500
Amoxicillin 128 256 256 256 256 256 256 0.500
Imipenem 1 1 1 8 16 4 8 0.125
Meropenem 2 16 4 16 16 16 16 0.0625
Cefepime 32 32 8 128 128 128 128 0.0625
Cefoxitin 8 64 32 128 64 64 64 0.125
Cefazolin 128 256 256 256 256 256 256 0.0625
Cefotaxime 128 128 256 256 256 256 256 0.0625
Ceftazidime 256 128 128 128 128 128 128 0.0625
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20-fold higher than the NDM-1 value. Regarding penicillins, the Q119X variants showed
lower Km values toward both benzylpenicillin and carbenicillin, with values ranging
from 5- to 50-fold less than the NDM-1 values. The kcat values for benzylpenicillin were
quite similar to the NDM-1 value except for Q119Y, with a kcat value about 3-fold lower
than the NDM-1 value, and Q119K, with a kcat value 4-fold higher than the NDM-1 value.
Concerning carbenicillin, the Q119X variants (not including Q119C) showed higher kcat
values.
All NDM-1 variants hydrolyzed ﬁrst-, second-, third-, and fourth-generation cepha-
losporins very efﬁciently (Table 2). Indeed, the kcat values calculated for cefazolin,
cefoxitin, and cefepime were higher than the NDM-1 values. Differences in the kcat
values determined with cefotaxime were observed among the Q119X variants. The
Q119V variant exhibited the same kcat value as NDM-1, the Q119E and Q119Y variants
showed lower kcat values, and the Q119C, Q119F, and Q119K variants showed higher
kcat values. Regarding ceftazidime, we observed different behavior among the Q119X
variants. For example, the Q119Y showed a kcat of 68 s1, a Km of 2 M, and a kcat/Km
TABLE 2 Kinetic parameters for Q119X mutants, compared with NDM-1, with some -lactams
Substrate and parametera NDM-1b Q119C Q119F Q119E Q119Y Q119V Q119K
Imipenem
kcat (s1) 64 69 336 41 79 229 393
Km (M) 35 50 157 40 30 65 90
kcat/Km (M1 s1) 1.83 1.38 2.14 1.02 2.63 3.52 4.37
Meropenem
kcat (s1) 75 252 1500 82 561 269 357
Km (M) 80 100 252 146 105 20 37
kcat/Km (M1 s1) 0.94 2.52 5.95 0.56 5.34 13.45 9.65
Benzylpenicillin
kcat (s1) 105 100 166 100 34 231 414
Km (M) 250 71 89 5c 8c 45 15
kcat/Km (M1 s1) 0.42 1.41 1.86 20.0 4.25 5.10 27.6
Carbenicillin
kcat (s1) 108 52 158 234 216 267 929
Km (M) 285 59 131 18 31 32 35
kcat/Km (M1 s1) 0.38 0.88 1.21 13.00 6.97 8.34 26.54
Cefazolin
kcat (s1) 42 48 169 63 561 269 125
Km (M) 20 11 27 4c 105 20 32
kcat/Km (M1 s1) 2.10 4.36 6.26 15.75 5.34 13.45 3.90
Cefoxitin
kcat (s1) 23 99 152 64 85 193 58
Km (M) 26 23 21 23 17 18 49
kcat/Km (M1 s1) 0.88 4.30 7.24 2.78 5.00 10.72 1.18
Cefotaxime
kcat (s1) 20 43 59 4 7 21 89
Km (M) 14 7c 6c 2c 2c 10c 3c
kcat/Km (M1 s1) 1.43 6.14 9.83 2.00 3.50 2.00 29.67
Ceftazidime
kcat (s1) 18.5 74 257 14 68 7 106
Km (M) 50 163 403 140 2c 3c 11
kcat/Km (M1 s1) 0.37 0.45 0.64 0.10 34.00 2.33 9.64
Cefepime
kcat (s1) 13 22 67 18 30 71 60
Km (M) 35 30 16 40 4c 10c 18
kcat/Km (M1 s1) 0.37 0.73 4.19 0.45 7.50 7.10 3.33
aEach kinetic value is the mean of ﬁve different measurements; the error was 5%.
bKinetic data for NDM-1 were from reference 15.
cKm values were determined as Ki values, using nitroceﬁn as the reporter substrate (19).
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value about 10-fold higher than the NDM-1 value. Cefepime, a fourth-generation
cephalosporin, was more stable than cefazolin, cefoxitin, cefotaxime, and ceftazidime
with all NDM-1 variants. For all Q119X variants (with rare exceptions), increases in the
catalytic efﬁciency (kcat/Km), compared with NDM-1, were detected with all -lactams
examined (Table 3). In particular, the Q119E, Q119Y, Q119V, and Q119K variants showed
signiﬁcant improvements in kcat/Km for penicillins, due to lower Km values. The catalytic
efﬁciencies of the Q119K variant for benzylpenicillin and carbenicillin were about 65-
and 70-fold higher, respectively, than those of NDM-1. The Q119K and Q119Y enzymes
had kcat/Km values for ceftazidime about 25- and 89-fold higher, respectively, than that
of NDM-1. The Q119E variant showed high catalytic efﬁciencies with penicillins but
lower efﬁciencies with carbapenems and ceftazidime. The replacement of glutamine
(Q) with cysteine (C), phenylalanine (F), glutamic acid (E), tyrosine (Y), valine (V), or
lysine (K) considerably increased the activity of NDM-1 for some -lactams, such as
benzylpenicillin, carbenicillin, meropenem (except Q119E), ceftazidime (particularly
true for Q119Y and Q119K), and cefepime (particularly true for Q119Y and Q119V).
However, no clear correlation between the MIC values and the kinetic data could be
observed, mainly because the MIC values for the majority of substrates did not differ
substantially between wild-type NDM-1 and the mutants. For cefazolin, cefoxitin, and
meropenem, the Q119V variant was always the most efﬁcient enzyme (up to 10-fold
greater than NDM-1), followed by Q119F and Q119E (about 2- to 5-fold greater than
NDM-1). For benzylpenicillin, carbenicillin, cefotaxime, ceftazidime, and meropenem,
Q119K was the most efﬁcient enzyme, with catalytic efﬁciencies about 66-, 69-, 20-, 25-,
and 10-fold higher, respectively, than those of NDM-1.
Residue 119 is positioned in the L5 loop, which includes important catalytic residues
such as H116, H118, and D120. Q119 is adjacent to D120 and we presume that it could
play an important role in the activities of NDM-1. Structural studies of NDM-1 (18)
suggested that Q119 maintains the correct orientation of H118 and D120 in the Zn-1
coordination and therefore plays a major role in the catalytic properties of NDM-1. The
study by Chiou et al. demonstrated that Q119D and Q119A mutants showed reduced
carbapenem, ampicillin, and cefepime MIC values and Q119D showed reductions in kcat
values for the same -lactams (18); this seems to be a discrepancy with respect to the
results obtained with our mutants, for which substitutions at position 119 led to
enzymes with major activity, compared to the wild-type NDM-1 enzyme. The results
obtained in the present study suggest that the involvement of residue 119 in NDM-1
activity is related to the amino acid structure. Our results highlight this position as a
good candidate for the evolution of the NDM MBLs.
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TABLE 3 Ratios of kcat/Km values for NDM-1 and mutants
Substrate
kcat/Km for Q119X variant/kcat/Km for NDM-1
Q119C Q119F Q119E Q119Y Q119V Q119K
Benzylpenicillin 3.4 4.4 47.6 10.1 12.1 65.7
Carbenicillin 2.3 3.2 34.2 18.3 21.9 69.8
Imipenem 0.7 1.2 0.6 1.4 1.9 2.4
Meropenem 2.7 6.3 0.6 5.7 14.3 10.3
Cefazolin 2.1 2.9 7.5 2.5 6.4 1.9
Cefoxitin 4.9 8.2 3.2 5.7 12.2 1.3
Cefotaxime 4.3 6.9 1.4 2.4 1.4 20.7
Ceftazidime 1.9 1.7 0.3 89.5 6.1 25.4
Cefepime 2.0 11.3 1.2 20.3 19.2 9.0
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